Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 6,034 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity Clear all

Conditions: Overweight, Obesity, Diabetes Mellitus, Type 2
Interventions: Tirzepatide, Acetaminophen; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Hialeah, Florida

Conditions: Obesity, Overweight, Type 2 Diabetes Mellitus
Interventions: Maridebart Cafraglutide, Placebo; Biological · Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 592 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 29
States / cities: Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 20 more

Conditions: Overweight and Obesity
Interventions: Almonds, Pretzels; Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 30 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Obesity
Interventions: Weight Loss Maintenance + Healthy Thinking, Weight Loss Maintenance Treatment + Future Thinking; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 70 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Overweight , Obesity, Class I Obesity
Interventions: Low-processed DGA Diet, Ultra-processed DGA Diet; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Weight Loss
Interventions: Weekly Incentive; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Weight Loss, Obesity
Interventions: Byetta (exenatide), Weight loss, Metabolic Chamber, Placebo; Drug · Behavioral · Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Obesity
Interventions: Bimagrumab, Tirzepatide, Calcium/Vitamin D, Lifestyle and nutrition counseling; Drug · Dietary Supplement · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overweight and Obesity
Interventions: high dairy diet, Low Dairy; Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 20 Years to 50 Years
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Davis, California

Conditions: Venous Thrombosis, Venous Insufficiency
Interventions: Not listed
Lead sponsor: University of Vermont; Other
Eligibility: 40 Years to 79 Years
Enrollment: 2,211 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Pain, Inflammatory Response
Interventions: Moderate Fat Meal, High Fat Meal; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: PreDiabetes, Insulin Resistance, Overweight, Obesity
Interventions: Palmitoleic acid, Placebo; Dietary Supplement · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Smoking, Obesity
Interventions: smoking cessation program, weight control program; Behavioral
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 1,778 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Olanzapine, Quetiapine; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 25
States / cities: Garden Grove, California • La Mesa, California • San Diego, California + 22 more

Conditions: Obesity, Physical Activity, Diet, Stress
Interventions: Tu Salud Si Cuenta Worksite Intervention; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Brownsville, Texas • Harlingen, Texas

Conditions: Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2, Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy, Age 18-64 Years
Interventions: Omentectomy, No intervention; Procedure · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 64 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: Zonisamide; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Overweight and Obesity, Healthy
Interventions: Breakfast: control meal, Breakfast: Cinnamon meal, Breakfast: Italian herbs meal, Breakfast: pumpkin spice; Other
Lead sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Childhood Obesity
Interventions: Family Connections; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 6 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Obesity, Weight Loss, Gastrectomy
Interventions: Gastric Point of Care Ultrasound; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Diabetes, Insulin Resistance
Interventions: High Intensity Interval Training (HIIT); Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: Sigmoidoscopy; Procedure
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 35 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Obesity, Overweight, Diabetes Mellitus, Type 2
Interventions: LY4167586, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 617 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 11
States / cities: Anaheim, California • Los Alamitos, California • Walnut Creek, California + 8 more

Conditions: Diabetes
Interventions: Virtual Reality Application; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 6 Years to 18 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Palo Alto, California

Search by objective public record fields.

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Effects of Almond Consumption on the Human Gastrointestinal Microbiota and Metabolic Health

Physical Activity Choices Everyday

Dietary Guidelines for Americans-Ultra Processed Study

Helping Employees Lose Pounds

The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

Dairy Foods and Weight Loss

Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome

Association Between Body Composition and Pain in Spinal Cord Injury

Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes

Theory-Based Interventions for Smoking and Obesity (Challenge) Trial

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Tu Salud Si Cuenta Worksite: Pilot Intervention Study

A Pilot Study of Metabolic Effects of Omentectomy

Zonisamide for Weight Reduction in Obese Adults

Reason to Season; Flavors to Increase Vascular Health

Family Connections: Cultural Adaptation and Feasibility Testing for Rural Latino Communities

Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery

Fuel Utilization, Diet Composition, and Exercise in African American Women

Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease

A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes

Virtual Reality as a Dietary Education Adjunct for Pediatric Patients With Obesity